Literature DB >> 8495323

Treatment of perforated sigmoid diverticulitis: a prospective randomized trial.

O Kronborg1.   

Abstract

A prospective randomized trial was carried out on 62 patients with diffuse peritonitis from perforated diverticulitis of the left colon, comparing acute transverse colostomy, suture and omental covering of a visible perforation with acute resection without primary anastomosis. For purulent peritonitis the postoperative mortality rate was significantly higher after acute resection (six of 25) than after colostomy (none of 21). In those treated by acute resection, the mortality rate was not significantly higher after Hartmann's procedure (five of 15) than after exteriorization of both lumens (one of ten). The postoperative mortality rate in patients with faecal peritonitis did not differ significantly between colostomy (six of ten) and acute resection (two of six). Stomas became permanent in four of 25 patients with diverticulitis surviving acute colostomy and in seven of 22 surviving acute resection. Suture and transverse colostomy is superior to resection for purulent peritonitis because of the lower postoperative mortality rate and in spite of the shorter hospital stay in those surviving acute resection.

Entities:  

Mesh:

Year:  1993        PMID: 8495323     DOI: 10.1002/bjs.1800800434

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  24 in total

1.  Perforated left-sided diverticulitis with faecal peritonitis: is the Hinchey classification the best guide for surgical decision making?

Authors:  V Naraynsingh; R Maharaj; D Hassranah; S Hariharan; D Dan; A P Zbar
Journal:  Tech Coloproctol       Date:  2011-01-27       Impact factor: 3.781

Review 2.  Epidemiology of perforated colonic diverticular disease.

Authors:  C R Morris; I M Harvey; W S L Stebbings; C T M Speakman; H J Kennedy; A R Hart
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

3.  Damage control strategy for the management of perforated diverticulitis with generalized peritonitis: laparoscopic lavage and drainage vs. laparoscopic Hartmann's procedure.

Authors:  Song Liang; Karla Russek; Morris E Franklin
Journal:  Surg Endosc       Date:  2012-04-28       Impact factor: 4.584

Review 4.  Minimally invasive surgical treatment of sigmoid diverticulitis.

Authors:  B D Barry; J Leroy; D Mutter; H-S Wu; J Marescaux
Journal:  Langenbecks Arch Surg       Date:  2012-05-31       Impact factor: 3.445

5.  Management of perforated diverticular disease.

Authors:  A Senapati; C G Marks
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

Review 6.  Mortality and complications following surgery for diverticulitis: Systematic review and meta-analysis.

Authors:  Jason M Haas; Maharaj Singh; Nimish Vakil
Journal:  United European Gastroenterol J       Date:  2015-11-13       Impact factor: 4.623

7.  One-stage sigmoid colon resection for perforated sigmoid diverticulitis (Hinchey stages III and IV).

Authors:  Sven Richter; Werner Lindemann; Otto Kollmar; Georg A Pistorius; Christoph A Maurer; Martin K Schilling
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

Review 8.  Treatment of Hinchey stage III-IV diverticulitis: a systematic review and meta-analysis.

Authors:  Roberto Cirocchi; Stefano Trastulli; Jacopo Desiderio; Chiara Listorti; Carlo Boselli; Amilcare Parisi; Giuseppe Noya; Liu Liu
Journal:  Int J Colorectal Dis       Date:  2012-12-15       Impact factor: 2.571

9.  Damage control surgery with abdominal vacuum and delayed bowel reconstruction in patients with perforated diverticulitis Hinchey III/IV.

Authors:  Reinhold Kafka-Ritsch; Franz Birkfellner; Alexander Perathoner; Helmut Raab; Hermann Nehoda; Johann Pratschke; Matthias Zitt
Journal:  J Gastrointest Surg       Date:  2012-07-28       Impact factor: 3.452

10.  Treatment of perforated diverticulitis with generalized peritonitis: past, present, and future.

Authors:  Jefrey Vermeulen; Johan F Lange
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.